Literature DB >> 10761599

[Congenital malarial disease due to Plasmodium falciparum in high-infection-risk newborn].

B Balaka1, A D Agbere, P Bonkoungou, K Kessie, K Assimadi, K Agbo.   

Abstract

UNLABELLED: The aim of this work was to differentiate in an endemic area congenital malaria diseases (CMD) from congenital malaria infestations (CMI) or other maternal-fetal infections.
METHODS: Four hundred and seventy-five newborn (0-7 d) suspected of infection were prospectively studied. CMD was diagnosed when clinical manifestations were associated with positive thick and thin blood films in a mother and her newborn. The diagnosis of CMI was retained when despite positive parasitemia, no clinical manifestations were observed.
RESULTS: Forty newborns (1.7% of the cases of maternal malaria) were diagnosed as CMD and ninety-one (19% of live births) were considered as CMI. The main clinical manifestations were related to cerebral (100%), respiratory (95%) and hemodynamic (90%) systems. Hematologic signs were present in 95% of cases. The level of parasitemia varied from 700 to 3,000 parasites/mL in CMD and from 360 to 870 parasites/mL in CMI. Death occurred in ten cases (25%) of CMD.
CONCLUSION: In this malaria-endemic area, neither clinical manifestions nor parasitemia allow one to distinguish CMD from CMI associated with bacterial materno-fetal infections. Studying placental or systemic immunity and antimalaria IgM in the newborn could be of interest to clarify this problem.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761599     DOI: 10.1016/s0929-693x(00)88739-4

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  5 in total

1.  Severe congenital malaria acquired in utero.

Authors:  Jeanne R Poespoprodjo; Afdal Hasanuddin; Wendelina Fobia; Paulus Sugiarto; Enny Kenangalem; Daniel A Lampah; Emiliana Tjitra; Ric N Price; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

2.  Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women.

Authors:  Nana O Wilson; Fatou K Ceesay; Samuel A Obed; Andrew A Adjei; Richard K Gyasi; Patricia Rodney; Yassa Ndjakani; Winston A Anderson; Naomi W Lucchi; Jonathan K Stiles
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Congenital Malaria and Its Associated Factors at Issaka Gazobi Maternity of Niamey in Niger.

Authors:  I Tahirou; M O Zara; M L Moustapha; M Kamayé; D Mahamadou; A Ibrahim; M Daou; A Soumana; M L Ibrahim
Journal:  Int J Pediatr       Date:  2020-10-17

4.  [Congenital Plasmodium falciparum malaria: epidemiological, clinical, biological, therapeutic and prognostic aspects in Ouagadougou, Burkina Faso].

Authors:  Kisito Nagalo; Fousséni Dao; Philippe Minodier; Oumarou Sawadogo; Harouna Sanon; François Housséini Tall; Diarra Yé
Journal:  Pan Afr Med J       Date:  2014-05-13

5.  Congenital cerebral malaria: a masquerader in a neonate.

Authors:  Ezinne I Nwaneli; Chisom A Nri-Ezedi; Kenneth N Okeke; Emeka S Edokwe; Sylvia T Echendu; Kenechukwu K Iloh
Journal:  Malar J       Date:  2022-02-05       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.